The FDA granted full approval to two drugs June 20 — Jardiance and Synjardy, both manufactured by Boehringer Ingelheim — for the treatment of pediatric Type 2 diabetes. Now, children with the condition will have three options for approved therapies.
Read the full post on Becker's Hospital Review - Healthcare News
